HIV-1 viral protein R (Vpr) induces fatty liver in mice via LXRα and PPARα dysregulation: implications for HIV-specific pathogenesis of NAFLD
出版年份 2017 全文链接
标题
HIV-1 viral protein R (Vpr) induces fatty liver in mice via LXRα and PPARα dysregulation: implications for HIV-specific pathogenesis of NAFLD
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-10-11
DOI
10.1038/s41598-017-13835-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients
- (2016) Élise Vuille-Lessard et al. AIDS
- Prevalence and predictors of liver steatosis and fibrosis in unselected patients with HIV mono-infection
- (2016) Rosa Lombardi et al. DIGESTIVE AND LIVER DISEASE
- Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy
- (2015) C. G. Morse et al. CLINICAL INFECTIOUS DISEASES
- High dietary protein intake, reducing or eliciting insulin resistance?
- (2014) A Rietman et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- New Clues to Understanding HIV Nonprogressors: Low Cholesterol Blocks HIV Trans Infection
- (2014) V. R. Prasad et al. mBio
- HIV-1 Vpr—a still “enigmatic multitaskerâ€
- (2014) Carolin A. Guenzel et al. Frontiers in Microbiology
- Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
- (2013) Jennifer E. Lambert et al. GASTROENTEROLOGY
- Human immunodeficiency virus and liver disease forum 2012
- (2013) Kenneth E. Sherman et al. HEPATOLOGY
- HIV-1 Vpr Induces Adipose Dysfunction in Vivo Through Reciprocal Effects on PPAR/GR Co-Regulation
- (2013) N. Agarwal et al. Science Translational Medicine
- De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health
- (2013) Leah Eissing et al. Nature Communications
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease
- (2012) Chiara Gabbi et al. DIGESTIVE AND LIVER DISEASE
- Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection
- (2012) Valentina Li Vecchi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- HIV-1 Vpr Triggers Mitochondrial Destruction by Impairing Mfn2-Mediated ER-Mitochondria Interaction
- (2012) Chih-Yang Huang et al. PLoS One
- Dietary Protein Affects Gene Expression and Prevents Lipid Accumulation in the Liver in Mice
- (2012) Jessica Schwarz et al. PLoS One
- Genome-Wide Profiling of Liver X Receptor, Retinoid X Receptor, and Peroxisome Proliferator-Activated Receptor in Mouse Liver Reveals Extensive Sharing of Binding Sites
- (2011) M. Boergesen et al. MOLECULAR AND CELLULAR BIOLOGY
- Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c
- (2010) P. Ferré et al. DIABETES OBESITY & METABOLISM
- Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: Implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis
- (2010) Ana C. Tuyama et al. HEPATOLOGY
- Nonalcoholic Fatty Liver Disease Among HIV-Infected Persons
- (2009) Nancy Crum-Cianflone et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Nonalcoholic Fatty Liver Disease in HIV‐Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors
- (2008) Giovanni Guaraldi et al. CLINICAL INFECTIOUS DISEASES
- Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection
- (2008) Richard K. Sterling et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started